$56.48
2.14% today
Nasdaq, Feb 28, 04:54 pm CET
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock price

$55.30
+3.44 6.63% 1M
-13.17 19.23% 6M
+21.54 63.80% YTD
+18.30 49.46% 1Y
+18.30 49.46% 3Y
+18.30 49.46% 5Y
+18.30 49.46% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-6.96 11.18%
ISIN
US88023B1035
Symbol
TEM

Key metrics

Market capitalization $8.71b
Enterprise Value $8.73b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 12.59
P/S ratio (TTM) P/S ratio 12.56
P/B ratio (TTM) P/B ratio 159.13
Revenue growth (TTM) Revenue growth 30.38%
Revenue (TTM) Revenue $693.40m
EBIT (operating result TTM) EBIT $-688.38m
Free Cash Flow (TTM) Free Cash Flow $-211.17m
Cash position $448.26m
EPS (TTM) EPS $-4.75
P/E forward negative
P/S forward 7.30
EV/Sales forward 7.31
Short interest 13.28%
Show more

Is Tempus AI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Tempus AI Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Tempus AI forecast:

5x Buy
45%
6x Hold
55%

Analyst Opinions

11 Analysts have issued a Tempus AI forecast:

Buy
45%
Hold
55%

Financial data from Tempus AI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
693 693
30% 30%
100%
- Direct Costs 325 325
28% 28%
47%
369 369
33% 33%
53%
- Selling and Administrative Expenses 703 703
176% 176%
101%
- Research and Development Expense 317 317
71% 71%
46%
-651 -651
300% 300%
-94%
- Depreciation and Amortization 37 37
12% 12%
5%
EBIT (Operating Income) EBIT -688 -688
251% 251%
-99%
Net Profit -706 -706
230% 230%
-102%

In millions USD.

Don't miss a Thing! We will send you all news about Tempus AI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tempus AI Stock News

Neutral
The Motley Fool
about 5 hours ago
Tempus AI (TEM -11.18%) is utilizing artificial intelligence to deliver better healthcare outcomes.
Positive
The Motley Fool
2 days ago
Only time will tell if the market enthusiasm that drove artificial intelligence (AI) stocks higher in 2024 will extend through 2025. But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve.
Positive
Seeking Alpha
2 days ago
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying opportunity due to raised 2025 revenue guidance. The company, a leader in healthcare AI, focuses on revenue growth and customer adoption, with a proprietary data model for personalized healthcare treatment. Despite stock volatility, Tempus AI's 30% organic revenue growth and Ambr...
More Tempus AI News

Company Profile

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Head office United States
CEO Eric Lefkofsky
Employees 2,400
Website www.tempus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today